Helgi Birgisson
Papers
1
Total Citations
12
H-Index
1
About
Helgi Birgisson is a cancer researcher whose work centers on the molecular mechanisms of colorectal cancer (CRC) and the development of diagnostic biomarkers. His most-cited study, “High sensitivity isoelectric focusing to establish a signaling biomarker for the diagnosis of human colorectal cancer” (2016, 12 citations), investigates how genetic alterations in the EGFR, KRAS, and BRAF pathways drive constitutive signaling in CRC. By applying high-sensitivity isoelectric focusing, Birgisson’s team identified a signaling biomarker that could improve early detection and diagnosis of this disease. This work bridges fundamental oncogenic pathway biology with practical clinical tools, offering a more precise approach to identifying CRC at a stage when intervention is most effective. Though his citation count is modest, the targeted impact of his research lies in its potential to translate complex signaling dynamics into actionable diagnostic tests. Birgisson’s contributions underscore the importance of linking genetic mutations to functional protein activity, providing a foundation for future studies on personalized cancer diagnostics and targeted therapies in colorectal oncology.
Research Focus
Key Achievements
Top Papers
- 1